Raymond James Financial
ROIV icon

Raymond James Financial’s Roivant Sciences ROIV Stock Holding History

Raymond James Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Buy
62,741
+36,605
+140% +$1.08M ﹤0.01% 3413
2026
Q1 		$724K Sell
26,136
-50,726
-66% -$1.3M ﹤0.01% 4090
2025
Q4 		$1.67M Buy
76,862
+52,225
+212% +$1.03M ﹤0.01% 3410
2025
Q3 		$373K Buy
24,637
+2,651
+12% +$32.8K ﹤0.01% 4286
2025
Q2 		$248K Buy
+21,986
New +$238K ﹤0.01% 4410
2025
Q1 		– Sell
-84,091
Closed -$995K – 4929
2024
Q4 		$995K Buy
+84,091
New +$994K ﹤0.01% 3454

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Raymond James Financial's ROIV Position: Q2 2026 in Review

Raymond James Financial increased its Roivant Sciences (ROIV) stake by 140% in Q2 2026, buying an estimated $1.08M and bringing the position to 62,741 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

Raymond James Financial first reported a position in ROIV in Q4 2024 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Raymond James Financial held 62,741 shares of Roivant Sciences worth $2.22M as of Q2 2026.
  • Raymond James Financial bought 36,605 Roivant Sciences shares in Q2 2026, an estimated $1.08M.
  • Roivant Sciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3413 holding.
  • Raymond James Financial first reported a position in Roivant Sciences in Q4 2024 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.